T1	Participants 87 121	postmenopausal osteoporotic women.
T2	Participants 137 240	paired biopsies of osteoporotic women treated with either strontium ranelate or a placebo for 36 months
T3	Participants 501 613	paired biopsies of osteoporotic women treated with either strontium ranelate (SrRan) or a placebo for 36 months.
T4	Participants 625 644	ten paired biopsies
